Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
258.8 GBX | +3.77% | +0.39% | +5.98% |
01:47pm | Deutsche Bank Begins Convatec Group Coverage with Buy Rating | MT |
10:16am | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 25.21 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 2.72 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.98% | 6.38B | B+ | ||
-3.62% | 184B | C+ | ||
-0.67% | 107B | C | ||
-2.93% | 69.44B | A | ||
+4.09% | 50.37B | B- | ||
+8.81% | 44.82B | B- | ||
+3.40% | 41.53B | B+ | ||
+3.35% | 26.84B | A- | ||
+3.66% | 26.73B | B | ||
+15.23% | 25.71B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CTEC Stock
- Ratings ConvaTec Group Plc